QGEN
Qiagen NVNYSEHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$6.74B
P/E Ratio
16.68
EPS
$1.96
Beta
0.64
52W High
$57.82
52W Low
$32.53
50-Day MA
$39.23
200-Day MA
$45.58
Dividend Yield
0.00%
Profit Margin
19.20%
Forward P/E
10.39
PEG Ratio
0.83
About Qiagen NV
QIAGEN NV provides sample-to-knowledge solutions that transform biological materials into molecular knowledge globally. The company is headquartered in Venlo, the Netherlands.
Fundamentals
| Revenue (TTM) | $2.10B |
| Gross Profit (TTM) | $1.39B |
| EBITDA | $727.68M |
| Operating Margin | 23.80% |
| Return on Equity | 11.90% |
| Return on Assets | 6.01% |
| Revenue/Share (TTM) | $10.18 |
| Book Value | $16.15 |
| Price-to-Book | 2.04 |
| Price-to-Sales (TTM) | 3.21 |
| EV/Revenue | 3.721 |
| EV/EBITDA | 11.24 |
| Quarterly Earnings Growth (YoY) | -23.80% |
| Quarterly Revenue Growth (YoY) | 1.80% |
| Shares Outstanding | $206.25M |
| Float | $204.90M |
| % Insiders | 0.47% |
| % Institutions | 81.73% |
Historical Volatility
HV 10-Day
33.96%
HV 20-Day
48.75%
HV 30-Day
43.28%
HV 60-Day
36.30%
HV Rank
87.3%
Volatility is currently contracting
Analyst Ratings
Consensus ($44.82 target)
3
Strong Buy5
Buy8
HoldMore HEALTHCARE Stocks
Data last updated: 5/14/2026